Suchergebnisse - "Uncommon mutation"

PubPharm (105)

1

Non-small cell lung cancer : an update on emerging EGFR-targeted therapies

enthalten in: Expert opinion on emerging drugs | 2024

von Favorito, V. | Ricciotti, I. | De Giglio, A. | +6

2

Successful therapy of a critically ill non-small cell lung cancer patient with compound mutations in EGFR G719X and S768I genes using furmonertinib : A case report

enthalten in: Heliyon | 2024

von Pan, X. | Shi, M.

3

Subtype of EGFR exon 19 deletion mutations

enthalten in: Translational lung cancer research | 2024

von Fujimoto, N.

CommentOn: Clin Cancer Res. 2023 Jun 1;29(11):2123-2130. - PMID 36913537

4

The treatment of patients with non-small cell lung cancer carrying uncommon EGFR mutations, HER2 mutations, or brain metastases : a systematic review of pre-clinical and clinical findings for dacomitinib

enthalten in: Translational cancer research | 2023

von Yang, L. | Luo, X. | Xie, L. | +2

5

Molecular epidemiology and clinical characteristics of epidermal growth factor receptor mutations in NSCLC : A single-center experience from India

enthalten in: Journal of cancer research and therapeutics | 2023

von Thomas, R. | Balaram, G. | Varayathu, H. | +10

6

Chemotherapy outcomes in EGFR-TKI resistant patients with common and uncommon EGFR mutation : An exploratory retrospective cohort study

enthalten in: Thoracic cancer | 2023

von Lin, C. | Hu, C. | Hsu, C. | +8

ErratumIn: Thorac Cancer. 2024 Feb 20;:. - PMID 38375557

7

Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations : A Narrative Review

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Jiang, Y. | Fang, X. | Xiang, Y. | +3

8

Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC) : New Lights for an Unmet Medical Need

enthalten in: International journal of molecular sciences | 2023

von Pretelli, G. | Spagnolo, C. | Ciappina, G. | +2

9

Case Report : The effective treatment of patients in advanced no-small cell lung cancer patients with EGFR G719X/S768I/L861Q and acquired MET amplification: A case series and literature review

enthalten in: Frontiers in oncology | 2023

von Zhao, Y. | Su, C. | Shi, L. | +7

10

Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan

in: Thoracic Cancer | 2023

von John Wen‐Cheng Chang | Chen‐Yang Huang | Yueh‐Fu Fang | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]